Novogene Co., Ltd. announced that it will received an equity round of funding on April 8, 2022. The transaction has been approved at the 2nd special shareholders' meeting for 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.39 CNY | +1.20% | -5.20% | -38.35% |
12/04 | Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
27/02 | Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.35% | 82Cr | |
-16.99% | 855.16Cr | |
+65.23% | 424.44Cr | |
-1.63% | 254.16Cr | |
-41.76% | 234.52Cr | |
-8.53% | 189.01Cr | |
-19.29% | 155.21Cr | |
-39.61% | 123.34Cr | |
+9.54% | 113.05Cr | |
+19.57% | 96Cr |
- Stock Market
- Equities
- 688315 Stock
- News Novogene Co., Ltd.
- Novogene Co., Ltd. announced that it expects to receive CNY 2.27307 billion in funding